HHS Secretary Alex Azar said on Friday (Nov. 16) that the department would continue to give Medicare Part D more tools to negotiate lower drug prices that are available in the private sector, echoing CMS Administrator Seema Verma’s similar statements earlier this week. Lobbyists anticipate that the Part D proposed rule , which is expected to be published soon, will include policies to reform the six Part D protected drug classes. “Today, we prevent Medicare Part D drug plans and...